Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life - PubMed (original) (raw)
Randomized Controlled Trial
. 2008 Jun;138(6):1091-5.
doi: 10.1093/jn/138.6.1091.
Affiliations
- PMID: 18492839
- DOI: 10.1093/jn/138.6.1091
Free article
Randomized Controlled Trial
Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life
Sertac Arslanoglu et al. J Nutr. 2008 Jun.
Free article
Abstract
A mixture of neutral short-chain galactooligosaccharides (scGOS) and long-chain fructooligosaccharides (lcFOS) has been shown to reduce the incidence of atopic dermatitis (AD) and infectious episodes during the first 6 mo of life. This dual protection occurred through the intervention period. The present study evaluated if these protective effects were lasting beyond the intervention period. In a prospective, randomized, double-blind, placebo-controlled design, healthy term infants with a parental history of atopy were fed either a prebiotic-supplemented (8 g/L scGOS/lcFOS) or placebo-supplemented (8 g/L maltodextrin) hypoallergenic formula during the first 6 mo of life. Following this intervention period, blind follow-up continued until 2 y of life. Primary endpoints were cumulative incidence of allergic manifestations. Secondary endpoints were number of infectious episodes and growth. Of 152 participants, 134 infants (68 in placebo, 66 in intervention group) completed the follow-up. During this period, infants in the scGOS/lcFOS group had significantly lower incidence of allergic manifestations. Cumulative incidences for AD, recurrent wheezing, and allergic urticaria were higher in the placebo group, (27.9, 20.6, and 10.3%, respectively) than in the intervention group (13.6, 7.6, and 1.5%) (P < 0.05). Infants in the scGOS/lcFOS group had fewer episodes of physician-diagnosed overall and upper respiratory tract infections (P < 0.01), fever episodes (P < 0.00001), and fewer antibiotic prescriptions (P < 0.05). Growth was normal and similar in both groups. Early dietary intervention with oligosaccharide prebiotics has a protective effect against both allergic manifestations and infections. The observed dual protection lasting beyond the intervention period suggests that an immune modulating effect through the intestinal flora modification may be the principal mechanism of action.
Similar articles
- Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life.
Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E. Arslanoglu S, et al. J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3 Suppl):49-59. J Biol Regul Homeost Agents. 2012. PMID: 23158515 Clinical Trial. - Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life.
Arslanoglu S, Moro GE, Boehm G. Arslanoglu S, et al. J Nutr. 2007 Nov;137(11):2420-4. doi: 10.1093/jn/137.11.2420. J Nutr. 2007. PMID: 17951479 Clinical Trial. - Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.
Schouten B, Van Esch BC, Kormelink TG, Moro GE, Arslanoglu S, Boehm G, Knippels LM, Redegeld FA, Willemsen LE, Garssen J. Schouten B, et al. Pediatr Allergy Immunol. 2011 Aug;22(5):537-42. doi: 10.1111/j.1399-3038.2010.01132.x. Pediatr Allergy Immunol. 2011. PMID: 21771085 Clinical Trial. - Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S. Halken S. Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review. - Prebiotics in infant formulas.
Boehm G, Jelinek J, Stahl B, van Laere K, Knol J, Fanaro S, Moro G, Vigi V. Boehm G, et al. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S76-9. doi: 10.1097/01.mcg.0000128927.91414.93. J Clin Gastroenterol. 2004. PMID: 15220664 Review.
Cited by
- Oligosaccharide composition of breast milk influences survival of uninfected children born to HIV-infected mothers in Lusaka, Zambia.
Kuhn L, Kim HY, Hsiao L, Nissan C, Kankasa C, Mwiya M, Thea DM, Aldrovandi GM, Bode L. Kuhn L, et al. J Nutr. 2015 Jan;145(1):66-72. doi: 10.3945/jn.114.199794. Epub 2014 Nov 19. J Nutr. 2015. PMID: 25527660 Free PMC article. - The hygiene hypothesis: current perspectives and future therapies.
Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB. Stiemsma LT, et al. Immunotargets Ther. 2015 Jul 27;4:143-57. doi: 10.2147/ITT.S61528. eCollection 2015. Immunotargets Ther. 2015. PMID: 27471720 Free PMC article. Review. - An Infant Formula with Large, Milk Phospholipid-Coated Lipid Droplets Supports Adequate Growth and Is Well-Tolerated in Healthy, Term Asian Infants: A Randomized, Controlled Double-Blind Clinical Trial.
Teoh OH, Lin TP, Abrahamse-Berkeveld M, Winokan A, Chong YS, Yap F, Marintcheva-Petrova M, van der Beek EM, Shek LP. Teoh OH, et al. Nutrients. 2022 Feb 1;14(3):634. doi: 10.3390/nu14030634. Nutrients. 2022. PMID: 35276993 Free PMC article. Clinical Trial. - Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial.
Rodriguez-Herrera A, Mulder K, Bouritius H, Rubio R, Muñoz A, Agosti M, Lista G, Corvaglia L, Ludwig T, Abrahamse-Berkeveld M, Perez-Navero JL. Rodriguez-Herrera A, et al. Nutrients. 2019 Jul 5;11(7):1530. doi: 10.3390/nu11071530. Nutrients. 2019. PMID: 31284424 Free PMC article. Clinical Trial. - Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.
Bawany F, Beck LA, Järvinen KM. Bawany F, et al. J Allergy Clin Immunol Pract. 2020 Mar;8(3):860-875. doi: 10.1016/j.jaip.2019.12.005. J Allergy Clin Immunol Pract. 2020. PMID: 32147139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical